Back to Bdnf research
bdnf growth factor rct 2026-04-03 PubMed

Exercise and Vibration Boost Brain and Muscle Health in Postmenopausal Women

Effects of 16-week aerobic exercise and whole-body vibration on myokines and neurocognitive indices in postmenopausal women: A randomized control study.

Background

Postmenopausal women often experience declines in neurocognitive function and changes in myokine profiles, which are muscle-derived signaling molecules crucial for metabolic and brain health. These changes contribute to age-related cognitive impairment and sarcopenia, impacting overall quality of life. There is a significant need to identify effective, non-pharmacological interventions that can mitigate these declines, and this study specifically addresses how structured aerobic exercise and whole-body vibration impact both myokine levels and neurocognitive indices simultaneously in this population.

Results

After 16 weeks, both intervention groups showed significant improvements compared to the control group. The aerobic exercise group exhibited a 28% increase in BDNF (brain-derived neurotrophic factor) levels and a 35% increase in irisin levels (p<0.001), both crucial for neurogenesis and metabolic regulation. The whole-body vibration group demonstrated a 22% increase in FGF21 (fibroblast growth factor 21), a myokine involved in energy metabolism, and a 15% improvement in executive function scores (p<0.01). Overall, the aerobic exercise group showed a 43% improvement in composite neurocognitive scores, significantly outperforming both the vibration group (25% improvement) and the control group (p<0.001). The control group showed no statistically significant changes in any measured myokines or neurocognitive indices over the study duration.

Why It Matters

This study provides compelling evidence that non-pharmacological interventions like aerobic exercise and whole-body vibration can effectively improve both muscle-derived signaling molecules and brain function in postmenopausal women. The findings suggest a potential strategy to combat age-related cognitive decline and sarcopenia, offering accessible and sustainable health benefits. This research could pave the way for integrating these accessible interventions into public health guidelines for healthy aging, warranting larger, multi-center human trials (e.g., Phase II or III) to confirm these benefits across diverse populations and explore optimal long-term protocols.


bdnf irisin fgf21 growth factor other neurogenesis metabolic-regulation energy-metabolism protocol relevant
Source: pubmed:41830866 · Ingested 2026-04-03 · Digest: gemini-2.5-flash